Human Genomics and Translational Data Sciences at Eli Lilly and Company

Boston, Massachusetts, United States

Eli Lilly and Company Logo
Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, HealthcareIndustries

Requirements

  • Visionary, passionate, and collaborative leader with deep understanding and significant track record of applying internal and external datasets for disease target identification, indication expansion, subpopulation classification, and disease mechanism understanding
  • Forward-thinking individual capable of pushing boundaries of scientific innovation using Lilly’s large in-house datasets and deep disease state expertise
  • Ability to lead and mentor a diverse team of in-house statistical geneticists and data scientists

Responsibilities

  • Provide scientific leadership and strategic vision in human genetics, proteomics, population data science, and clinical informatics to position Lilly at the forefront of genetics for diabetes, obesity, and complications
  • Lead and mentor a team with diverse computational background
  • Develop and implement strategies to optimally use public large-scale genetic/genomic resources (population-scale biobanks, genome sequencing initiatives) and integrate with patient-derived data from clinical trials to provide novel insights for Lilly’s portfolio
  • Lead efforts to analyze whole genome sequencing and proteomics data from clinical trial participants
  • Align with DOCTA’s strategic priorities and drive data-driven innovative approaches to identify and validate novel therapeutic targets
  • Spearhead cross-functional initiatives to translate genetic/genomic findings into actionable insights that inform drug discovery, biomarker development, and clinical trial design
  • Represent Lilly at scientific conferences and engage with the broader genetics/genomics community to stay at the forefront of innovation
  • Partner with internal teams to evaluate external innovation opportunities and bring insights to aid decision making
  • Interpret and clearly communicate results from genetic analyses, including development of scientific manuscripts, posters, and presentations; communicate the group’s vision and progress to internal and external stakeholders
  • Represent the Data Science and Computational Biology (DSCB) group and DOCTA both internally and externally, including partnering with key opinion leaders and identifying strategic alliance opportunities in the human genetics and metabolism space

Skills

Human Genomics
Genomics
Proteomics
Translational Data Science
Human Genetics
Clinical Research
Data Analysis
Disease Target Identification

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI